CD5 CAR T-cells

BIOLOGICAL2 trials

Sponsors

Zhejiang University

Conditions

T-Acute Lymphoblastic LeukemiaT-lymphoblastic Lymphoma

Early Phase 1

Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma

RecruitingNCT06633341

Zhejiang UniversityT-lymphoblastic Lymphoma

Start: 2024-10-20End: 2027-10-20Target: 30Updated: 2024-10-09

Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL

RecruitingNCT06633354

Zhejiang UniversityT-Acute Lymphoblastic Leukemia

Start: 2024-10-20End: 2027-10-20Target: 30Updated: 2024-10-09